These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20394493)

  • 21. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis.
    Chapman MS; Schachner LA; Breneman D; Boguniewicz M; Gold MH; Shull T; Linowski GJ; Jaracz E;
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S177-85. PubMed ID: 16021173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis.
    Hanifin JM; Paller AS; Eichenfield L; Clark RA; Korman N; Weinstein G; Caro I; Jaracz E; Rico MJ;
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S186-94. PubMed ID: 16021174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis.
    Patel RR; Vander Straten MR; Korman NJ
    Arch Dermatol; 2003 Sep; 139(9):1184-6. PubMed ID: 12975161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of adhesion molecules in atopic dermatitis is reduced by tacrolimus, but not by hydrocortisone butyrate: a randomized immunohistochemical study.
    Caproni M; Torchia D; Antiga E; Volpi W; Fabbri P
    Clin Exp Dermatol; 2006 Nov; 31(6):813-7. PubMed ID: 17040264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical tacrolimus treatment for chronic dermatitis of the ear.
    Harth W; Caffier PP; Mayelzadeh B; Haupt H; Sedlmaier B; Richard G
    Eur J Dermatol; 2007; 17(5):405-11. PubMed ID: 17673384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment.
    Antille C; Saurat JH; Lübbe J
    Arch Dermatol; 2004 Apr; 140(4):457-60. PubMed ID: 15096374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Topical tacrolimus in chronic actinic dermatitis].
    Girault PY; Boye T; Veran Y
    Ann Dermatol Venereol; 2008 Oct; 135(10):688-90. PubMed ID: 18929923
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis.
    Schuller E; Oppel T; Bornhövd E; Wetzel S; Wollenberg A
    J Allergy Clin Immunol; 2004 Jul; 114(1):137-43. PubMed ID: 15241357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
    Wollenberg A; Reitamo S; Atzori F; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
    Allergy; 2008 Jun; 63(6):742-50. PubMed ID: 18445188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus.
    Hengge UR; Krause W; Hofmann H; Stadler R; Gross G; Meurer M; Brinkmeier T; Frosch P; Moll I; Fritsch P; Müller K; Meykadeh N; Marini A; Ruzicka T; Gollnick H
    Br J Dermatol; 2006 Nov; 155(5):1021-8. PubMed ID: 17034535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study to determine the effect of tacrolimus on ceramide levels in the stratum corneum of patients with atopic dermatitis.
    Paslin D; Wertz P
    Int J Dermatol; 2006 Apr; 45(4):352-6. PubMed ID: 16650156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and safety of tacrolimus ointment: a clinical review.
    Beck LA
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S165-70. PubMed ID: 16021171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
    Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
    J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life in patients with atopic dermatitis: impact of tacrolimus ointment.
    Kawashima M;
    Int J Dermatol; 2006 Jun; 45(6):731-6. PubMed ID: 16796638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis.
    Nivenius E; van der Ploeg I; Jung K; Chryssanthou E; van Hage M; Montan PG
    Eye (Lond); 2007 Jul; 21(7):968-75. PubMed ID: 16680103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.